[ad_1]
Dublin, Feb. 09, 2022 (GLOBE NEWSWIRE) — The “Global Antifungal Agents Market 2021-2027” report has been added to ResearchAndMarkets.com’s offering.
The global antifungal agents market is estimated to grow at a significant CAGR of nearly 3.5% during the forecast period
The rise in the prevalence of infections such as aspergillosis and candidiasis has been significantly driving the market. Another major factor propelling the growth of the market include the rise in incidences of fungal infection. As per the Centers for Disease Control and Prevention (CDC), in 2017, there were nearly 23,000 cases of invasive candidiasis in the US.
Fungal diseases cost $7.2 billion in direct medical costs in 2017. 75,000 hospitalizations and nearly 9 million outpatient visits were reported due to fungal diseases in 2017. This, in turn, is encouraging the demand for antifungal agents that can fight fungal infection without damaging cells of the body.
Furthermore, medical advancements that include ongoing drug discovery and public-private initiatives to treat fungal diseases are driving market growth. Additionally, evolving opportunities in emerging economies such as the development of advanced healthcare infrastructure facilities are also expected to propel the growth of the market.
The COVID-19 pandemic has led to an increased demand for anti-fungal agents in the market. The patients hospitalized for the treatment of COVID-19 are at risk of healthcare-associated infections including candidemia or bloodstream infections that are caused by Candida. Additionally , the rise in the number of cases of black fungus, white …
Full story available on Benzinga.com
[ad_2]
Source link
